Sale!

UQCC2 Gene Mitochondrial Complex III Deficiency Nuclear Type 7 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The UQCC2 Gene Mitochondrial Complex III Deficiency Nuclear Type 7 NGS Genetic DNA Test is a cutting-edge genetic diagnostic tool that identifies mutations in the UQCC2 gene responsible for mitochondrial complex III deficiency. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to provide accurate detection of nuclear type 7 mitochondrial disorders. Patients experiencing symptoms such as developmental delays, muscle weakness, neurological issues, or metabolic abnormalities should consider this test. The test provides crucial information for diagnosis, treatment planning, and genetic counseling. Available for only $500 USD, this advanced genetic analysis helps identify inherited mitochondrial conditions and guides appropriate medical management strategies for affected individuals and their families.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

UQCC2 Gene Mitochondrial Complex III Deficiency Nuclear Type 7 NGS Genetic DNA Test

Comprehensive Introduction to Mitochondrial Complex III Deficiency Testing

Mitochondrial complex III deficiency represents a rare but serious group of inherited metabolic disorders affecting the electron transport chain, which is essential for cellular energy production. The UQCC2 gene plays a critical role in the assembly and stability of mitochondrial complex III, and mutations in this gene lead to nuclear type 7 mitochondrial disease. Our advanced NGS Genetic DNA Test provides comprehensive analysis of the UQCC2 gene to identify pathogenic variants responsible for this debilitating condition.

This specialized genetic test is particularly important because mitochondrial disorders often present with complex, multi-system symptoms that can be challenging to diagnose through conventional methods. By utilizing cutting-edge Next-Generation Sequencing technology, we offer unparalleled accuracy in detecting UQCC2 gene mutations, enabling precise diagnosis and personalized treatment approaches for affected individuals.

What This Advanced Genetic Test Detects

The UQCC2 Gene Mitochondrial Complex III Deficiency Nuclear Type 7 NGS Genetic DNA Test specifically analyzes:

  • Complete sequencing of the UQCC2 gene coding regions
  • Detection of point mutations, insertions, and deletions
  • Identification of pathogenic variants affecting complex III assembly
  • Assessment of mitochondrial respiratory chain function implications
  • Evaluation of inheritance patterns for genetic counseling

Technical Methodology

Our test employs state-of-the-art Next-Generation Sequencing (NGS) technology, which allows for comprehensive analysis of the entire UQCC2 gene with exceptional accuracy and sensitivity. This advanced approach enables detection of even rare variants that might be missed by traditional sequencing methods.

Who Should Consider UQCC2 Genetic Testing

This specialized genetic test is recommended for individuals presenting with:

  • Unexplained developmental delays in infancy or childhood
  • Progressive muscle weakness and exercise intolerance
  • Neurological symptoms including seizures or ataxia
  • Metabolic abnormalities such as lactic acidosis
  • Family history of mitochondrial disorders
  • Unexplained multi-organ system involvement
  • Suspected mitochondrial disease based on clinical presentation
  • Previous inconclusive metabolic testing results

Pediatric Considerations

Children presenting with failure to thrive, developmental regression, or unusual metabolic patterns should be evaluated for mitochondrial complex III deficiency. Early diagnosis through genetic testing can significantly impact treatment outcomes and quality of life.

Significant Benefits of UQCC2 Genetic Testing

Undergoing UQCC2 Gene Mitochondrial Complex III Deficiency testing provides numerous advantages:

  • Accurate Diagnosis: Provides definitive diagnosis for complex mitochondrial disorders
  • Personalized Treatment: Enables targeted therapeutic interventions based on genetic findings
  • Family Planning: Offers crucial information for genetic counseling and reproductive decisions
  • Prognostic Information: Helps predict disease progression and potential complications
  • Early Intervention: Facilitates timely management strategies to optimize outcomes
  • Research Contribution: Contributes to ongoing understanding of mitochondrial diseases

Understanding Your Test Results

Our comprehensive genetic testing provides detailed results with expert interpretation:

Positive Results

A positive result indicates the presence of pathogenic variants in the UQCC2 gene associated with mitochondrial complex III deficiency. Our genetic counselors will provide detailed explanations of the specific mutation, its implications for disease severity, and recommendations for management and surveillance.

Negative Results

A negative result suggests that no pathogenic variants were detected in the UQCC2 gene. However, this does not completely rule out mitochondrial disease, as other genetic or environmental factors may be involved. Further evaluation may be recommended based on clinical presentation.

Variant of Uncertain Significance (VUS)

In some cases, genetic variants of uncertain significance may be identified. These require careful clinical correlation and may necessitate additional family studies for proper interpretation.

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $500
Regular Price $700

Test Specifications

  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Methodology: Next-Generation Sequencing (NGS) Technology
  • Specialty: Pediatrics and Genetics
  • Disease Category: Dysmorphology and Mitochondrial Disorders

Pre-Test Preparation Requirements

To ensure optimal testing outcomes, we recommend:

  • Comprehensive clinical history documentation
  • Genetic counseling session prior to testing
  • Development of detailed family pedigree chart
  • Review of previous diagnostic testing results
  • Discussion of testing implications and potential outcomes

Nationwide Testing Availability

We proudly offer UQCC2 Gene Mitochondrial Complex III Deficiency testing services across the United States, with convenient locations in all major metropolitan areas including:

  • New York City and surrounding regions
  • Los Angeles and Southern California
  • Chicago and Midwest locations
  • Houston, Dallas, and Texas facilities
  • Phoenix and Southwest testing centers
  • Miami, Atlanta, and Southeastern locations
  • Seattle, Portland, and Pacific Northwest centers

Take Action for Better Health Outcomes

Don’t let uncertainty about mitochondrial disorders delay proper diagnosis and treatment. Our UQCC2 Gene Mitochondrial Complex III Deficiency Nuclear Type 7 NGS Genetic DNA Test provides the clarity needed for effective medical management. With our discounted price of $500 USD and comprehensive nationwide availability, accessing advanced genetic testing has never been more convenient.

Ready to schedule your genetic test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Our team is available to answer your questions, discuss testing options, and guide you through the entire process with compassion and expertise.

Early genetic diagnosis can make a significant difference in managing mitochondrial disorders and improving quality of life. Take the first step toward understanding your genetic health today.